Summary.-This paper discusses the results of experiments using y-rays and a hypoxic sensitizer metronidazole (MET) and also a well-known protector, mercaptoethylamine (MEA), individually and in combination, on the survival of the yeast S. cerevisiae BZ 34. MET (5mM) gave a hypoxic enhancement ratio (ER) of 13. MEA (5mM, 10mM) gave a dose-modifying factor (DMF) of 19 and 2-3 respectively for euoxic cells. However, the DMFs for hypoxic cells were 1.0 and 1-1 for 5 and 10mM concentrations of MEA. A combination of 5mM MEA and 5mM MET gave a DMF of 2-0 for euoxic cells and the ER remained at 1-3 for hypoxic cells. The "effective" oxygen enhancement ratios were 2-3 and 1-7 for the control and the sensitizer respectively. In the combination this value was equal to or even slightly less than 1. All DMF, ER and OER values were derived from Do values of the survival curves. The values based on 10% survival are almost equal to those derived from Do values. All the survival curves gave the same extrapolation number, showing that the chemicals individually or in combination were truly dose-modifying.
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These results indicate that protectors such as MEA could be preferentially protecting euoxic cells, and that combining such "oxic protectors" with a hypoxic sensitizer could result in protecting euoxic cells while the sensitization of hypoxic cells was not much reduced. The implications of our results for radiotherapy are discussed. It appears that the use of nontoxic oxic protectors may be a useful adjuvant in overcoming the hypoxic-cell problem in radiotherapy.
THE PRESENCE of hypoxic cells in tumours may contribute to the failure of radiation therapy because of their greater resistance to radiation than that of the euoxic cells. Possibilities for dealing with this problem are the use of (1) hyperbaric oxygen; (2) fractionated therapy schedules; (3) high-LET radiation, or (4) hypoxic sensitizers. The recent interest generated in sensitizers which preferentially sensitize hypoxic cells has led to consideration of their use in radiotherapy (Adams and Cooke, 1969;  Denekamp, Michael and Harris, 1974;  Moore, Palcic and Skarsgard, 1976; Foster and Willson, 1973; Asquith et al., 1974; Chapman et al., 1972) . Recent clinical trials show encouraging results which may be of help in radiation therapy (Urtasun et al., 1975 (Urtasun et al., , 1977 Deutsch et al., 1975; Thomlinson et al., 1976 (Maisin, LambietCollier and Mattelin, 1976) . Recently Utley et al. (1974) have shown that the compound WR-2721 had differential protection for hypoxic and euoxic cells in vivo, and suggested that it could be used in radiotherapy. Similar observations with the same compound were made by Yuhas (1973) . To reduce the toxic effect of the protectors, a combination of protectors was recently proposed (Maisin et al., 1976; Sztanyik and Santha, 1976) . Similar studies on the combination of hypoxic sensitizers of different modes of action are also being actively pursued (Millar, Fielden and Smithen, 1977) . We have shown hypoxic sensitization by MET on survival of yeast and favourable split-dose recovery properties (Krishnan et al., 1977, Krishnan et al., unpublished) . Many radioprotective substances are known to protect well oxygenated cells to a greater extent than relatively hypoxic cells (Alper, 1962; Bridges, 1962; Antoku, 1975 (Krishnan et al., 1977) . MEA solutions were adjusted to pH 6-5-7-0 with dilute NaOH just before use. Final concentrations used for experiments were 5 and 10mM. The combination of MEA and MET consisted of 5mM each.
Toxicity studies of chemicals.-Before radiation experiments were done the chemicals were tested individually and in combination for toxicity to yeast, suspended in sterile distilled water both under euoxic and hypoxic conditions. The toxicities were usually checked at the highest concentrations and over the longest contact times, used in the experiments. For toxicity studies, 106 cells/ml in euoxic conditions or 108 cells/ml in hypoxic conditions were kept in the chemical solution for the required length of time at room temperature. Production of hypoxic condition.-For irradiation under hypoxic conditions, the autoanoxia method of Pohlit (1973) , as detailed elsewhere (Krishnan et al. 1977) , was used. Pyrex volumetric-standard vial (1 or 2ml capacity) with ground-glass tight fitting stopper was filled fully without air bubbles, with a cell suspension of 108 cells/ml and tightly stoppered. These samples were incubated for 30 min at 30°C. An oxygen consumption rate of 2-2 x 10-16 mol/cell/min by the concentrated cell suspension (10 cells/ ml) ensures hypoxic condition within 20 min (Pohlit, 1973) .
Irradiation and dosimetry.-All irradiations were done in a gamma cell (Isotope Division, BARC) at a dose rate of 5-5 krad/min and a transit dose of 500 rad per operation. The dose at various positions inside the irradiation chamber was measured using the Fricke dosimeter. It was observed that there was appreciable (5%) difference in the dose rates at the centre and at the periphery of the chamber. Therefore all the samples for irradiation were kept along the annulus at the periphery of the irradiation chamber in a beaker 8 cm in diameter with packing in the centre. The same irradiation geometry was maintained for all the experiments. All the samples were irradiated within a total period of I h.
Treatment of samples.-One ml of cell suspension from the irradiated sample was filtered through a 0 45 ,um filter paper in a Millipore filter assembly. The filter paper was resuspended in 10 ml water and shaken in a Vortex shaker to get the cells in water. Appropriate dilutions were plated in 4 YEPD plates to get -250 colonies/plate, to avoid any errors arising from small numbers of colonies. Plating was done as soon as possible after irradiation, and the cells were kept at low temperature (4°C) between irradiation and filtering. The millipore filtering method of washing off the chemical was used whether the samples contained the chemical or not, so that all the samples went through the same procedure.
RESULTS

General
The diploid yeast S. cerevisiae BZ 34 used for all these studies has a shouldered (Foster and Willson, 1973; Denekamp et at., 1974) . We have also found (Krishnan et al., 1977) an enhancement ratio of 1-3 at ImM MET on our yeast system. However, 0.1, I and 10mM MET gave similar survival curves. For the sake of later comparison this graph is reproduced as Fig. 1 Effect of a combination of MEA and MET As shown above, MET sensitizes hypoxic cells with an ER of 1-3 and MEA preferentially protects euoxic cells with a DMF of 2*3. A combination of hypoxic sensitizer with a chemical protector preferentially protecting euoxic cells will protect euoxic (normal) cells while the hypoxic cells remain sensitized, provided the combination is free of interaction. To test this hypothesis we have used a combination of MET and MEA at equimolar (5mM) concentrations. y-Ray survival curves using this combination are given in Fig. 3 . The combination gave a survival curve for hypoxic cells identical to that of the hypoxic sensitizer (Lines 4 and 6 in Fig. 3) . The combination gave a survival curve for euoxic cells with a DMF of 1 7 (Line 5 in Fig. 3 ). The slope of the survival curve of hypoxic cells with the combination of 2-3 ± 0 1 1-7 --0-1 1-2 -I 0-1 0-86 -0 1 1.1 10.1 chemicals is actually even slightly less than that of euoxic cells with the same combination (0 86±0-05). It appears that the "hypoxic cell problem" could be overcome by using such a combination of chemicals. (Cohen and Cohen, 1959) both with microorganisms and with mammalian cells that protection by chemical agents is less effective when no oxygen is present during irradiation". She also suggested that an agent could be found which would protect the aerobic normal cells more effectively than the anoxic tumour cells. Yuhas and Storer (1969) have also found that the thiophosphate compound WR-2721 protected irradiated healthy tissues in a tumour-bearing mouse, but did not protect the tumour itself. Harris and Phillips (1971) , Utley et al., (1974) and Phillips (1977) have reported similar results. All these reports indicate that some radioprotective chemicals can show a differential protection of euoxic cells rather than hypoxic cells. From Fig. 2 it can be seen that the differential protection of MEA is considerable in our in vitro studies.
The OER value, as seen in Table I , reduces when MET is present because of its property of specifically sensitizing hypoxic cells. Similarly the differential production of MEA for euoxic cells reduces OER.
Extension of our results to radiotherapy
Results of in vitro split-dose experiments with RO-07-0582 (Hall and RoizinTowle, 1975) and MET (Krishnan et al., unpublished) Table II gives the OER values expected on the basis of these assumed parameters. It can be seen that the expected OER values for a combination of chemicals with y-rays is midway between those of fast neutrons and high LET radiation. Thus it appears that using a mixture of hypoxic sensitizer and oxic protector might make y radiation itself as useful as other radiations for radiotherapy in so far as the "hypoxic cell problem" is concerned. However, one is While revising our manuscript we came across a recent paper by Yuhas et al. (1977) . These workers have used a combination of WR-2721, a radioprotective chemical, and RO-07-0582, a hypoxic radiosensitizer, on transplanted tumours in mice. Their results are in line with our in vitro studies.
